Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Edward S. Torres

Affiliations

  • Large Shareholder at Surface Oncology Inc. (SURF), 2018-04-23
  • Other at Aileron Therapeutics Inc (ALRN), 2017-07-07
  • Large Shareholder at Protagonist Therapeutics Inc (PTGX), 2016-08-16
  • Large Shareholder at Aeglea Biotherapeutics Inc. (AGLE), 2016-04-06
  • Director at Globeimmune Inc (GBIM), 2016-03-21
  • Director at Receptos Inc. (RCPT), 2015-08-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GBIM $10.00 85,000 Director 267,894 2014-07-08 Filing
RCPT $14.00 142,857 Director 2,081,210 2013-05-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GBIM $1.67 26,188 Director 241,706 2016-03-17 Filing
RCPT $182.89 50,400 Director 665,561 2015-06-16 Filing
RCPT $175.54 88,400 Director 715,961 2015-06-15 Filing
RCPT $180.33 81,200 Director 804,361 2015-06-12 Filing
RCPT $130.15 7,200 Director 885,561 2015-02-27 Filing